Treatment of EBV and KHSV Infection and Associated Abnormal Cellular Proliferation

A method and composition for the treatment, prevention and/or prophylaxis of a host, and in particular, a human, infected with Epstein-Barr virus (EBV), is provided that includes administering an effective amount of a 5-substituted uracil nucleoside or its pharmaceutically acceptable salt or prodrug, optionally in a pharmaceutically acceptable diluent or excipient.

Patents:
US 20,100,168,052

Inventor(s): SCHINAZI RAYMOND F [US]; SHI JUNXING [US]; GUSTAFSON ERIK [US]; FINGEROTH JOYCE D [US]

Type of Offer: Licensing



« More Medical Patents

---